News on H. Lundbeck A%2FS from BioPortfolio.com http://www.BioPortfolio.com Consolidated H. Lundbeck A%2FS news from BioPortfolio.com Wed, 10 Feb 2010 03:12:12 GMT en Adeona Appoints James S. Kuo, M.D., M.B.A., as Chairman, CEO and Presidenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034800&HITNO=0&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034800&THISHREF=http://c.moreover.com/click/here.pl%3fz2535981936%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034800&HITNO=0&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034800&THISHREF=http://c.moreover.com/click/here.pl%3fz2535981936%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Adeona Pharma (AEN) Appoints James Kuo as CEO and Presidenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034854&HITNO=1&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034854&THISHREF=http://c.moreover.com/click/here.pl%3fz2536014164%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034854&HITNO=1&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034854&THISHREF=http://c.moreover.com/click/here.pl%3fz2536014164%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Scientists in the vanguard of dissenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025539&HITNO=2&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025539&THISHREF=http://c.moreover.com/click/here.pl%3fz2529894549%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025539&HITNO=2&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025539&THISHREF=http://c.moreover.com/click/here.pl%3fz2529894549%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDeccan Herald: Syracuse Man Charged With Stealing Trade Secretshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025061&HITNO=3&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025061&THISHREF=http://c.moreover.com/click/here.pl%3fz2529396434%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025061&HITNO=3&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025061&THISHREF=http://c.moreover.com/click/here.pl%3fz2529396434%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Syracuse Man Charged With Stealing Trade Secretshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024757&HITNO=4&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024757&THISHREF=http://c.moreover.com/click/here.pl%3fz2529153040%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024757&HITNO=4&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024757&THISHREF=http://c.moreover.com/click/here.pl%3fz2529153040%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKSLA: AstraZeneca, Merck, Novartis, H. Lundbeck, Hoffman LaRoche and GlaxoSmithKline Explore Advances in Solubility,http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018229&HITNO=5&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018229&THISHREF=http://c.moreover.com/click/here.pl%3fz2525532804%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018229&HITNO=5&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018229&THISHREF=http://c.moreover.com/click/here.pl%3fz2525532804%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Pharma IQ to organize 4th Improving Solubility conference at The Park Hyatt in Philadelphiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020064&HITNO=6&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020064&THISHREF=http://c.moreover.com/click/here.pl%3fz2526580085%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020064&HITNO=6&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020064&THISHREF=http://c.moreover.com/click/here.pl%3fz2526580085%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Shape of Barrett's epithelium effects prevalence of erosive esophagitishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021620&HITNO=7&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021620&THISHREF=http://c.moreover.com/click/here.pl%3fz2527291983%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021620&HITNO=7&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021620&THISHREF=http://c.moreover.com/click/here.pl%3fz2527291983%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: AstraZeneca, Merck, Novartis, H. Lundbeck, Hoffman LaRoche and GlaxoSmithKline Explore Advances in Solubility, Amorphous Forms ..http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014692&HITNO=8&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014692&THISHREF=http://c.moreover.com/click/here.pl%3fz2524121600%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014692&HITNO=8&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014692&THISHREF=http://c.moreover.com/click/here.pl%3fz2524121600%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: AstraZeneca, Merck, Novartis, H. Lundbeck, Hoffman LaRoche and GlaxoSmithKline Explore Advances in Solubility, Amorphous Forms and Lipid-Based Formulahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017002&HITNO=9&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017002&THISHREF=http://c.moreover.com/click/here.pl%3fz2524971837%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017002&HITNO=9&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017002&THISHREF=http://c.moreover.com/click/here.pl%3fz2524971837%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: AstraZeneca, Merck, Novartis, H. Lundbeck, Hoffman LaRoche and GlaxoSmithKline Explore Advances in Solubility, Amorphous Forms and Lipid-Based Formulation of Drugshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014575&HITNO=10&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014575&THISHREF=http://c.moreover.com/click/here.pl%3fz2524061001%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014575&HITNO=10&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014575&THISHREF=http://c.moreover.com/click/here.pl%3fz2524061001%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: AstraZeneca, Merck, Novartis, H. Lundbeck, Hoffman LaRoche and GlaxoSmithKline Explore Advances in Solubility, Amorphous Forms and Lipid-Based Formulation of Drugshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014591&HITNO=11&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014591&THISHREF=http://c.moreover.com/click/here.pl%3fz2524064343%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014591&HITNO=11&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014591&THISHREF=http://c.moreover.com/click/here.pl%3fz2524064343%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire via Yahoo!: AstraZeneca, Merck, Novartis, H. Lundbeck, Hoffman LaRoche and GlaxoSmithKline Explore Advances in Solubility, Amorphous Forms and Lipid-Based Formulation of Drugshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016476&HITNO=12&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016476&THISHREF=http://c.moreover.com/click/here.pl%3fz2524776653%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016476&HITNO=12&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016476&THISHREF=http://c.moreover.com/click/here.pl%3fz2524776653%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: AstraZeneca, Merck, Novartis, H. Lundbeck, Hoffman LaRoche and GlaxoSmithKline Explore Advances in Solubility, Amorphous Forms ahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015149&HITNO=13&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015149&THISHREF=http://c.moreover.com/click/here.pl%3fz2524295966%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015149&HITNO=13&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015149&THISHREF=http://c.moreover.com/click/here.pl%3fz2524295966%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: AstraZeneca, Merck, Novartis, H. Lundbeck, Hoffman LaRoche and GlaxoSmithKline Explore Advances in Solubility, Amorphous Forms ahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015104&HITNO=14&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015104&THISHREF=http://c.moreover.com/click/here.pl%3fz2524277290%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015104&HITNO=14&MSIZE=271&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=H.%20Lundbeck%20A/S&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015104&THISHREF=http://c.moreover.com/click/here.pl%3fz2524277290%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: